Cargando…

Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway

Backgrounds: The circadian clock protein Rev-erbα is a crucial regulator of circadian rhythms that affects multiple molecular, cellular, and physiology pathways that control susceptibility, injury, and recovery in the neurological disorders. Emerging evidence suggest that Rev-erbα plays a key role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Mingyue, Chen, Xun, Yu, Yan, Wu, Qi, Kou, Junping, Chen, Gangling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102520/ https://www.ncbi.nlm.nih.gov/pubmed/37063298 http://dx.doi.org/10.3389/fphar.2023.1102567

Ejemplares similares

In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011
por: Geldof, Lore, et al.
Publicado: (2016)

REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish
por: Saiz, Nuria, et al.
Publicado: (2022)

Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells
por: Wagner, Paula M., et al.
Publicado: (2019)

SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
por: Li, Hui, et al.
Publicado: (2022)

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
por: Xu, Hang, et al.
Publicado: (2022)

SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy
por: Shen, Weitao, et al.
Publicado: (2020)

The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
por: Ishimaru, Kayoko, et al.
Publicado: (2019)

Circadian Clock REV-ERBs Agonist SR9009 Induces Synergistic Antitumor Activity in Multiple Myeloma by Suppressing Glucose-Regulated Protein 78-Dependent Autophagy and Lipogenesis
por: Wang, Rui, et al.
Publicado: (2023)

The Effect of Rev-erbα Agonist SR9011 on the Immune Response and Cell Metabolism of Microglia
por: Wolff, Samantha E. C., et al.
Publicado: (2020)

Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
por: Gao, Li‐Bin, et al.
Publicado: (2021)

REV-ERB is essential in cardiac fibroblasts homeostasis
por: Luo, Xiaokang, et al.
Publicado: (2022)

Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012)

Chronoeffects of the Herbal Medicines Puerariae radix and Coptidis rhizoma in Mice: A Potential Role of REV-ERBα
por: Liu, Jinming, et al.
Publicado: (2021)

SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis
por: Hu, Ming, et al.
Publicado: (2022)

Scutellaria baicalensis Georgi regulates REV-ERBα/BMAL1 to protect against skin aging in mice
por: Sun, Guanghui, et al.
Publicado: (2022)

Downregulation of REV-ERBα is associated with the progression of lung adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
por: Ikeda, Ryosuke, et al.
Publicado: (2019)

REV-ERB activation as a novel pharmacological approach for treating inflammatory pain
por: Makhija, Sangeet, et al.
Publicado: (2023)

Puerariae lobatae radix protects against UVB-induced skin aging via antagonism of REV-ERBα in mice
por: Ma, Luyao, et al.
Publicado: (2022)

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists
por: Solt, Laura A., et al.
Publicado: (2012)

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle
por: Amador, Ariadna, et al.
Publicado: (2018)

Rev-erbα Inhibits Proliferation and Promotes Apoptosis of Preadipocytes through the Agonist GSK4112
por: Chu, Guiyan, et al.
Publicado: (2019)

Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
por: Murray, Meghan H., et al.
Publicado: (2022)

Development and implementation of a cell-based assay to discover agonists of the nuclear receptor REV-ERBα
por: Hering, Yuliya, et al.
Publicado: (2018)

REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice
por: Shao, Ruyue, et al.
Publicado: (2021)

Rev-erb Agonist Inhibits Chikungunya and O’nyong’nyong Virus Replication
por: Hwang, Jesse, et al.
Publicado: (2018)

Novel Function of Rev-erbα in Promoting Brown Adipogenesis
por: Nam, Deokhwa, et al.
Publicado: (2015)

Rev-erbα in the brain is essential for circadian food entrainment
por: Delezie, Julien, et al.
Publicado: (2016)

Targeting REV-ERBα for therapeutic purposes: promises and challenges
por: Wang, Shuai, et al.
Publicado: (2020)

Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models
por: Zhang, Tianpeng, et al.
Publicado: (2021)

REV-ERBα regulates age-related and oxidative stress-induced degeneration in retinal pigment epithelium via NRF2
por: Huang, Shuo, et al.
Publicado: (2022)

Ruscogenin Prevents Folic Acid-Induced Acute Kidney Damage by Inhibiting Rev-erbα/β-Mediated Ferroptosis
por: Hu, Mingyue, et al.
Publicado: (2022)

Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model
por: Yue, Jiong, et al.
Publicado: (2020)

The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity
por: Gerhart-Hines, Zachary, et al.
Publicado: (2013)

REV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor
por: Okabe, Takashi, et al.
Publicado: (2016)

The Nuclear Receptor and Clock Repressor Rev-erbα Suppresses Myogenesis
por: Chatterjee, Somik, et al.
Publicado: (2019)

REV-ERBα Regulates T(H)17 Cell Development and Autoimmunity
por: Amir, Mohammed, et al.
Publicado: (2018)

Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer
por: Ke, Chen, et al.
Publicado: (2022)

RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer
por: Wang, Xiaoshan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gpjapfo11spjf91r65p6qt55el